Orajel Gum Pain 3X Medicated benzocaine, menthol, zinc chloride 200 mg/g; 1.5 mg/g; 2.6 mg/g Gel, 1 tube — NDC 10237-792-42 (Billing 10237-0792-42)
This is a package of 1 tube of Orajel Gum Pain 3X Medicated benzocaine, menthol, zinc chloride 200 mg/g; 1.5 mg/g; 2.6 mg/g Gel from Church & Dwight Co., Inc., marketed since Dec 2019 and currently FDA-listed.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 2362013
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Standardized Chemical Allergen class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Orajel Gum Pain 3X is a topical gel marketed as an over-the-counter oral pain reliever under FDA's OTC monograph rules. It contains benzocaine, a local anesthetic typically used to numb minor mouth and gum pain, along with menthol, which is commonly included for a cooling sensation. The product also includes zinc chloride, which is typically used in oral care products for its astringent properties. This gel is applied directly to the affected gum area to provide temporary relief from minor pain.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 10237-0792-12 10237-792-12 Main listing | 1 TUBE in 1 PACKAGE / 3.5 g in 1 TUBE | 2019-12-17 | — | Active |
| 10237-0792-42 You're viewing this | 1 TUBE in 1 CARTON / 11.9 g in 1 TUBE | 2019-12-17 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 10237-0792-12?
What NDC number is used to bill for this package of Orajel Gum Pain 3X Medicated benzocaine, menthol, zinc chloride 200 mg/g; 1.5 mg/g; 2.6 mg/g Gel?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Orajel Rescue Relief Pen 1.5 mg/g; 2.6 mg/g; 200 mg/g 10237-0731-07 | Church | 1 applicator | — | — | FDA listed | — |
| Orajel 3X Medicated For Toothache and Gum 2.6 mg/g; 200 mg/g; 1.5 mg/g 10237-0790-12 | Church | 1 tube | — | — | FDA listed | — |
| Orajel Gum Pain 3X Medicated 200 mg/g; 1.5 mg/g; 2.6 mg/gthis 10237-0792-42 | Church | 1 tube | — | — | FDA listed | — |
| 3X Medicated Toothache and Gum Gel 20 g/100g; .26 g/100g; .15 g/100g 11822-0613-09 | Rite | 1 tube | — | — | FDA listed | — |
| DG 3x Medicated Toothache adn Gum Gel 20 g/100g; .15 g/100g; .26 g/100g 55910-0816-69 | Dollar | 1 tube | — | — | FDA listed | — |
| 3x Medicated Toothache and Gum Gel 20 g/100g; .26 g/100g; .15 g/100g 69842-0693-39 | CVS | 1 tube | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Use for the temporary relief of pain due to minor irritation or injury of the mouth and gums
⏱️ Dosage and Administration ▾
Directions Adults and children 2 years of age and older Apply to affected area up to 4 times daily or as directed by a dentist or doctor Children between 2 and 12 years of age Ask a doctor before use. Should be supervised in the use of this product Children under 2 years of age Do not use
⚠️ Warnings ▾
Warnings Methemoglobinemia warning : use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray, or blue colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, fatigue or lack of energy Allergy alert : do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other "caine" anesthetics
🧪 Active Ingredient ▾
Active ingredients Benzocaine 20% Menthol 0.26% Zinc chloride 0.15%
🧪 Inactive Ingredients ▾
Inactive ingredients ammonium glycyrrhizate, flavor, PEG-8, PEG-75, sodium saccharin, sorbic acid, water
🎯 Purpose ▾
Purpose Oral pain reliever and Oral astringent
📄 Do Not Use ▾
Do not use
Do not use more than directed for more than 7 days unless directed by a dentist or doctor for teething in children under 2 years of age
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if symptoms do not improve in 7 days swelling, rash or fever develops irritation, pain or redness persists or worsens
📄 Keep Out of Reach of Children ▾
Keep out of reach of children In case of overdose or allergic reaction, get medical help or contact a Poison Control Center right away
📄 Other Information ▾
Other information do not use if Tamper-Evident Tab is open before first use
📄 Questions or Comments ▾
Questions or comments? call us at 1-800-952-5080 M-F 9am-5pm ET or visit our website at www.orajel.com
📄 Package Label / Principal Display Panel ▾
Principal Display Panel #1 ORAL PAIN RELIEVER BRAND FOR ADULTS Open Tube Tip Orajel GUM PAIN 3X MEDICATED GEL INSTANT PAIN RELIEF 20% Benzocaine to Relieve Gum Pain Cooling Relief to Soothe Gums Relieves Gum Irritation ORAL PAIN RELIEVER/ASTRINGENT NET WT 0.125oz (3.5g) CR2_DA2044058_OJFC-00500-01_72016656
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |